Results 211 to 220 of about 7,812 (251)

CRISPR-Cas9 mediated endogenous utrophin upregulation improves Duchenne Muscular Dystrophy

, 2023
Guiraud S, Dastidar S, Mazed F, Amor F, Ralu M, de Cian A, Richard I, Ronzitti G, Tedesco FS, Amendola M.   +9 more
europepmc   +1 more source

Friend or Foe?: The Immune System's Dilemma With Dystrophin Replacement Therapy. [PDF]

JACC Basic Transl Sci
Townsend D.
europepmc   +1 more source

Spontaneous Calcium Bursts Organize the Apical Actin Cytoskeleton of Multiciliated Cells. [PDF]

Int J Mol Sci
Wiegel J, Helmstädter M, Walz G, Bergen MD.   +3 more
europepmc   +1 more source

GSK3 inhibition improves skeletal muscle function and whole-body metabolism in male mouse models of Duchenne muscular dystrophy. [PDF]

Nat Commun
Marcella BM, Hockey BL, Braun JL, Whitley KC, Geromella MS, Baranowski RW, Watson CJF, Silvera S, Hamstra SI, Wasilewicz LJ, Crozier RWE, Marais AAT, Kim KH, Lee G, Vandenboom R, Roy BD, MacNeil AJ, MacPherson REK, Fajardo VA.   +18 more
europepmc   +1 more source

Research hotspots and trends for Duchenne muscular dystrophy: a machine learning bibliometric analysis from 2004 to 2023. [PDF]

Front Immunol
Fang P, Han J, An D, Bu Y, Ji G, Liu M, Deng J, Guo M, Han X, Wu H, Ma S, Song X.   +11 more
europepmc   +1 more source

Respiratory performance in Duchenne muscular dystrophy: Clinical manifestations and lessons from animal models. [PDF]

Exp Physiol
Delaney R, O'Halloran KD.
europepmc   +1 more source

Benfotiamine improves dystrophic pathology and exercise capacity in mdx mice by reducing inflammation and fibrosis. [PDF]

Hum Mol Genet
Coles CA, Woodman KG, Gibbs EM, Crosbie RH, White JD, Lamandé SR.   +5 more
europepmc   +1 more source

Progress and prospects in antisense oligonucleotide-mediated exon skipping therapies for Duchenne muscular dystrophy. [PDF]

J Muscle Res Cell Motil
Chwalenia K, Wood MJA, Roberts TC.
europepmc   +1 more source

Utrophin in therapy of Duchenne muscular distrophy

, 2001
openaire   +2 more sources

Impaired hydrogen sulfide biosynthesis underlies eccentric contraction-induced force loss in dystrophin-deficient skeletal muscle. [PDF]

J Clin Invest
Southern WM, Johnson EE, Fasbender EK, Fallon KS, Cavazos CL, Lowe DA, Rodney GG, Ervasti JM.   +7 more
europepmc   +1 more source